|
Re: Ok hepalink down 9.2%
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 12:08AM
|
|
Re: Offering still available....
|
3
|
Resverlogix Corp.
|
May 28, 2019 05:26PM
|
|
Re: Off topic article of possible interest
|
1
|
Resverlogix Corp.
|
Sep 05, 2017 03:24PM
|
|
Re: Odd trade!!
|
|
Resverlogix Corp.
|
Apr 27, 2018 02:46AM
|
|
Re: Objectivity requires facts....we don't have them all yet
|
3
|
Resverlogix Corp.
|
May 16, 2019 05:07AM
|
|
Re: Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardio Benefits at Euro Society of Cardiology Congress 2024
|
8
|
Resverlogix Corp.
|
Sep 03, 2024 12:19PM
|
|
Re: Number of shares to compute the price per share
|
4
|
Zenith Epigenetics
|
Oct 04, 2017 01:14AM
|
|
Re: Number of shares to compute the price per share
|
2
|
Zenith Epigenetics
|
Oct 04, 2017 10:19AM
|
|
Re: Number of outstanding warrants + impact
|
4
|
Resverlogix Corp.
|
Nov 25, 2019 08:25PM
|
|
Re: NR: Resverlogix Highlights Key Accomplishments and 2018 Targets...
|
3
|
Resverlogix Corp.
|
Feb 09, 2018 04:12PM
|
|
Re: NR: Resverlogix Highlights Key Accomplishments and 2018 Targets...
|
2
|
Resverlogix Corp.
|
Feb 09, 2018 04:18PM
|
|
Re: NR on phase 1 Kidney Trial
|
3
|
Resverlogix Corp.
|
Jan 23, 2017 12:37PM
|
|
Re: Now that we're a small cap stock....
|
2
|
Resverlogix Corp.
|
Jul 12, 2018 12:19PM
|
|
Re: Now that we're a small cap stock....
|
3
|
Resverlogix Corp.
|
Jul 12, 2018 01:32PM
|
|
Re: Now recruiting: ZEN-3694 and Talazoparib in Patients With Triple Negative Breast Cancer (TNBC)
|
4
|
Zenith Epigenetics
|
May 06, 2019 06:09PM
|
|
Re: Novavax
|
5
|
Resverlogix Corp.
|
Mar 01, 2023 09:07PM
|
|
Re: Novartis' canakinumab (Ilaris)
|
6
|
Resverlogix Corp.
|
Mar 13, 2018 02:25PM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
8
|
Resverlogix Corp.
|
Jun 22, 2017 03:12PM
|
|
Re: Notice anything different about #11
|
|
Zenith Epigenetics
|
Oct 26, 2023 08:14PM
|
|
Re: Not So Fast Mister
|
7
|
Resverlogix Corp.
|
Jun 09, 2018 01:27AM
|
